Transforming drug development by rapidly and quantitatively measuring the affinities of millions of protein-protein interactions - we're hiring!
Seattle, WA
Joined April 2018
- Tweets112
- Following262
- Followers915
- Likes207
A-Alpha Bio retweeted
Excited to share our new paper using AlphaSeq data to enable predictive ML models for antibody engineering with our wonderful collaborators at @Google and @LumenBio
biorxiv.org/content/10.1101/…
A-Alpha Bio retweeted
Excited to announce our latest paper on ML-guided design of single-domain antibodies against CoV-2; A collaboration between @GoogleDeepMind, @AAlphaBio and @LumenBio.
A-Alpha Bio retweeted
Don't miss our first Founded & Funded of the year! @CPicardo talks w/ @AAlphabio's @DavidAYounger about #ML in #biotech, building business models around data, and when the CEO shouldn't be in the room! Full episode 👉 bit.ly/3IpfxGt What advice do you have for founders?
A-Alpha Bio retweeted
It was a pleasure speaking with @CPicardo from @MadronaVentures about @AAlphaBio and building a company at the intersection of life science and data science. Thank you for featuring A-Alpha Bio in the first Founded and Funded podcast of 2023!
This week on Founded & Funded, @CPicardo is talking with @DavidAYounger from @AAlphaBio — the first biotech company to make the #IA40. They dive into #ML in #biotech, building cross-functional teams & having both tech and biotech-focused investors. 👂 👉 bit.ly/3IpfxGt
A-Alpha Bio retweeted
Applied machine/deep learning & #lifesciences are coming together to transform how we understand & improve life/health. We want to partner w/ teams focused on building wet/dry lab platforms & novel datasets to disrupt traditional drug discovery processes. bit.ly/3FTANT5
A-Alpha Bio retweeted
A special thank you to our alumni sponsors who participated in previous Genome Startup Day discussions & continue to support our events. We appreciate your contributions to making this an impactful and collaborative community.
@TwinStrandBio, @AAlphaBio, @WatchmakerGeno @seqWell
A-Alpha Bio retweeted
We are thrilled to share we've raised $41.5M in our Series B that will grow our team and expand our product portfolio! Thanks to Marshall Wace and @JHIAdvisors for co-leading the round. Check out the release for even more details hubs.la/Q0149Y620 #singlecell #tech #vc
A-Alpha Bio retweeted
@KymeraTx is thrilled to partner with @AAlphaBio to discover and characterize novel pairs of E3 ubiquitin ligases and high-value therapeutic targets for the rational and prospective design and development of molecular glues.
We're delighted to share that we have partnered with @KymeraTx to take on the field of targeted protein degradation! Using our AlphaSeq assay, we'll identify novel interactions between high value undruggable targets and a library of E3 ubiquitin ligases to discover mol glues(1/3)
A-Alpha Bio retweeted
Our September nwsltr is out: bit.ly/CoMoNews0921. Links to stories about @UW #spinoffs @AAlphaBio & @Membrion recent fundraising rounds, UW #researcher spotlight on @UWlinguistics assistant professor Dr. Naja Ferjan Ramírez, #CoMotionLabs members @EqualizeHealth + more
A-Alpha Bio retweeted
Awesome work on your Series A, @AAlphaBio! 🎉 A big step forward for the development of potential treatments for COVID-19 and other diseases. geekwire.com/2021/university…
A-Alpha Bio retweeted
Founder Spotlight - @DavidAYounger at @AAlphaBio 🧫
Learn more about David and A-Alpha Bio's story here! medium.com/bios-community/fo…
#startups#VC #founder #synbio
A-Alpha Bio retweeted
Robust de novo design of protein binding proteins from target structural information alone
biorxiv.org/content/10.1101/…
A-Alpha Bio retweeted
Honored to see our work on #deeplearning for protein structure prediction featured on the cover of @ScienceMagazine. Research was led by the tremendously talented @minkbaek.
Article: science.sciencemag.org/conte…
Commentary: science.sciencemag.org/conte…
A-Alpha Bio retweeted
Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants news-medical.net/news/202104… @biorxivpreprint @AAlphaBio #SARSCOV2 #COVID19 #covid #coronavirus #pandemic #antibodies #therapeutics #therapy #monoclonal
A-Alpha Bio retweeted
Hacking the hiring process 🌟
We asked: @AAlphaBio, @Gordian_Bio, @anagenex, @DimensionInx, @rarebasepbc, @tierrabio, @getlabs, Slope, @OchreBio, Clarahealth, & @envedabio
“What is a seemingly random hack you found proved helpful in the hiring process?”
ow.ly/o3xX50Erz78
A-Alpha Bio retweeted
How do you bring safe new drugs to market, faster? OS Fund portfolio company @AAlphaBio uses their AlphaSeq technology to sort through millions of protein interactions simultaneously. Learn more at bit.ly/32GXeVn
A-Alpha Bio retweeted
NEW BLOG feat. @AAlphaBio CEO David Younger
"...When you’re doing this type of work with a group of people you really respect, the lows are still low, but the highs are just so much higher..."
LINK: blog.foster.uw.edu/inside-aa…
#UW #Entrepreneurship @UWCoMotion @uwengineering
A-Alpha Bio retweeted
Our schedule is up for #GenomeStartupDay! Stay tuned next week for our #weekofspeakers highlighting each of our featured startups and their founders. Read more about the event genomestartupday.com @AAlphaBio @PhaseGenomics @Split_Bio @TwinStrandBio @junglainc
A-Alpha Bio retweeted
The latest in BioCentury's Emerging Company series profiles @UWproteindesign spinout @AAlphaBio, which is hijacking yeast mating to optimize and drug protein-protein interactions #BCEmergingCompanyProfile buff.ly/31NeE1J
A-Alpha Bio retweeted
Announcing the inaugural #GenomeStartupDay! Join us @Split_Bio, @AAlphaBio, @junglainc, and other #Seattle biotech startups on September 23 at @uwgenome for a day dedicated to commercializing discoveries in the lab. Register for free today! @GenomeStartup genomestartupday.com/